www.fdanews.com/articles/72339-biophan-signs-loi-for-license-to-mri-technology
Biophan Signs LOI for License to MRI Technology
May 16, 2005
Biophan Technologies has executed a letter of intent (LOI) with German biomedical researchers Arno Bucker and Alexander Ruebben for an exclusive license to their breakthrough cardiovascular stent technology enabling accurate magnetic resonance imaging (MRI) angiography of the interior of vascular stents. The technology, developed by Bucker and Ruebben through their research at the University of Aachen in Germany, is designed to enable MRI visualizations to diagnose the health of implanted stents and assess the occurrence of restenosis, or unhealthy re-narrowing of stented arteries.